gptkbp:instance_of
|
gptkb:healthcare_organization
|
gptkbp:bfsLayer
|
8
|
gptkbp:bfsParent
|
gptkb:Mycoplasma_mycoides
|
gptkbp:affects
|
gptkb:dog_breed
|
gptkbp:caused_by
|
Mycoplasma mycoides subsp. mycoides
|
gptkbp:clinical_trial
|
gptkb:historical_event
weight loss
anorexia
increased respiratory rate
abnormal lung sounds
|
gptkbp:controls
|
vaccination campaigns
surveillance programs
culling infected animals
movement restrictions
|
gptkbp:current_use
|
gptkb:healthcare_organization
pleuropneumonia
|
gptkbp:distribution
|
gptkb:Africa
gptkb:Europe
gptkb:Asia
|
gptkbp:economic_impact
|
loss of livestock
reduced milk production
|
gptkbp:end_of_life
|
high in untreated cases
|
gptkbp:first_described_by
|
gptkb:19th_century
|
gptkbp:historical_significance
|
trade impact
major livestock disease
|
https://www.w3.org/2000/01/rdf-schema#label
|
contagious bovine pleuropneumonia
|
gptkbp:incubation_period
|
2 to 6 weeks
|
gptkbp:is_protected_by
|
gptkb:quarantine_measures
vaccination
|
gptkbp:is_vulnerable_to
|
variable
inactivated vaccine
live attenuated vaccine
|
gptkbp:larval_stage
|
gptkb:dog_breed
|
gptkbp:reports_to
|
gptkb:Food_and_Agriculture_Organization
gptkb:World_Organisation_for_Animal_Health
|
gptkbp:research_focus
|
vaccine development
pathogen genomics
disease control strategies
|
gptkbp:social_responsibility
|
gptkb:Mycoplasma_mycoides
gptkb:Middle_East
gptkb:Central_Asia
East Africa
Southern Africa
West Africa
clinical examination
serological tests
|
gptkbp:symptoms
|
cough
fever
difficulty breathing
nasal discharge
|
gptkbp:transmission
|
direct contact
|
gptkbp:treatment
|
antibiotics
supportive care
|
gptkbp:type_of
|
gptkb:physicist
|
gptkbp:wildlife
|
gptkb:battle
|